Nadine C. Lamla

Lead Immuno Oncology Global Marketing team and lead creation and execution of commercial strategy for one molecule

Lead global pipeline marketing in therapeutic area cardio renal metabolic for one molecule in obesity and NASH indications

Lead global cardiology strategy and activities of two heart failure indication launches of a triple blockbuster SGLT2i within the Eli Lilly and Boehringer Ingelheim Alliance.

Build and lead neurology franchise of Lilly Germany managing the marketing team, leading the cross-functional team and implementation with sales force and in digital channels.

Lead global strategy and activities of two oral type 2 diabetes franchise brands within the Eli Lilly and Boehringer Ingelheim Alliance.

Lead regional strategy and implementation of activities to launch the first SGLT2i in type 2 diabetes in the Asia Pacific region compassing 13 countries and leading the cross-functional Integrated Brand Value Team

Lead primary care, women’s health, gastroenterology, central nervous system and lifecycle management franchise managing the marketing team and leading implementation of activities with sales forces, partnerships and alternative channels.

Lead global activities of growth hormone product incl. launch of a new patient device.

Lead strategy and execution of contraceptive patch in private and institutional market segments managing the marketing team and implementation of activities with sales force, digital and PR as well as DTC.

Specialized in Marketing, Foreign Trade, Controlling and International Projects Award for Best Master Thesis of the Year 2003